Procter & Gamble (P&G) has announced its intention to
outsource the active pharmaceutical ingredient (API) R&D and
manufacturing work undertaken at one of its US factories, with
resultant closure of the site and job losses.
Most drug companies are not planning to increase the level of sales
and marketing IT they outsource over the next 3-5 years - a sign
that this niche segment may be bucking the wider pharmaceutical
industry outsourcing trend.
Affiliated Computer Services (ACS), announced today that it has
been awarded an additional information technology (IT) outsourcing
contract with GlaxoSmithKline (GSK), valued at $100.5 million (€82
million) over five years.